Combination drug strategy produces promising results by hyperactivating oncogenic signaling
Health Medicine Network,
FGF2 impairs cell cycle progression in K-Ras-driven cancer cells. Serum-starved Y1D1 cells were stimulated by 10% serum with or…
FGF2 impairs cell cycle progression in K-Ras-driven cancer cells. Serum-starved Y1D1 cells were stimulated by 10% serum with or…
A combination of two drugs was capable of suppressing tumors in a non-conventional manner. Instead of inhibiting tumor cell…